ASHLEY HODGENS: Open Payments
NPI 1649733494 · HOOVER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 23 payments from 5 companies in 2025. Trend: 2023 $5,991 · 2024 $970 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $242 |
| PFIZER INC. | 6 | $114 |
| Gilead Sciences, Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Amgen Inc. | 1 | $18 |
Products named: EMBLAVEO, ELIQUIS, DALVANCE, Veklury, Kerendia, TEFLARO, REPATHA.
Industry payments across AL — which companies pay providers there.
